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To gain more insight into initiation and regulation of T cell receptor (TCR) gene 
rearrangement during human T cell development, we analyzed TCR gene rearrangements by 
quantitative PCR analysis in nine consecutive T cell developmental stages, including CD34
 
 
 
 
lin
 
 
 
 cord blood cells as a reference. The same stages were used for gene expression profiling 
using DNA microarrays. We show that TCR loci rearrange in a highly ordered way (
 
TCRD
 
-
 
TCRG
 
-
 
TCRB
 
-
 
TCRA
 
) and that the initiating D
 
 
 
2-D
 
 
 
3 rearrangement occurs at the most 
immature CD34
 
 
 
CD38
 
 
 
CD1a
 
 
 
 stage. 
 
TCRB
 
 rearrangement starts at the CD34
 
 
 
CD38
 
 
 
CD1a
 
 
 
 
stage and complete in-frame 
 
TCRB
 
 rearrangements were first detected in the immature 
single positive stage. 
 
TCRB
 
 rearrangement data together with the 
 
PTCRA
 
 (pT
 
 
 
) expression 
pattern show that human TCR
 
 
 
-selection occurs at the CD34
 
 
 
CD38
 
 
 
CD1a
 
 
 
 stage. By 
combining the TCR rearrangement data with gene expression data, we identified candidate 
factors for the initiation/regulation of TCR recombination. Our data demonstrate that a 
number of key events occur earlier than assumed previously; therefore, human T cell 
development is much more similar to murine T cell development than reported before.
 
T cells develop from progenitors that migrate
from the bone marrow into the thymus (1).
Thymocytes are subdivided roughly as being
double negative (DN), double positive (DP),
or single positive (SP), based on the expression
of the CD4 and CD8 coreceptors (1). The
DN stage is heterogeneous and can be subdi-
vided into four distinct subsets in mice based
on the expression of CD44 and CD25. In hu-
man, three distinct DN stages can be recog-
nized: a CD34
 
 
 
CD38
 
 
 
CD1a
 
 
 
 stage that
represents the most immature thymic subset
and the consecutive CD34
 
 
 
CD38
 
 
 
CD1a
 
 
 
and CD34
 
 
 
CD38
 
 
 
CD1a
 
 
 
 stages. Human DN
thymocytes mature via an immature single
positive (ISP CD4
 
 
 
) and a DP stage into
CD4
 
 
 
 or CD8
 
 
 
 SP T cells that express func-
tional T cell receptors (TCR) and that exit the
thymus (1).
A hallmark of T cell development is the
generation of T cells that express a functional
TCR, TCR
 
  
 
 or TCR
 
  
 
. During T cell de-
velopment, the variable domains of 
 
TCRA
 
,
 
TCRB
 
,
 
 TCRG
 
, and 
 
TCRD
 
 (located within
 
TCRA
 
) genes are assembled following rear-
rangement of variable (V), diversity (D), and
joining (J) gene segments by a process called
V(D)J recombination (2). V(D)J recombination
uses the RAG1 and RAG2 enzymes that se-
lectively target recombination signal sequences
that flank V, D, and J segments (2).
Studies in T cell acute lymphoblastic leu-
kemias suggest that recombinations of TCR
genes are sequential between the different genes
(
 
TCRD
 
 
 
 
 
 
 
TCRG
 
 
 
 
 
 
 
TCRB
 
 
 
 
 
 
 
TCRA
 
) as well
as within a particular gene (e.g., 
 
TCRD
 
: D
 
 
 
2-
D
 
 
 
3, D
 
 
 
2-J
 
 
 
1, V
 
 
 
-J
 
 
 
1) (2, 3), which is sup-
ported by limited data that were obtained from
normal human T cell subsets (4). Therefore,
the timing and efficiency of rearrangement of
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Figure 1. RQ-PCR analysis of 
 
TCRD
 
 and 
 
TCRG
 
 gene rearrangements 
in human T cell development and mature T cells.
 
 (A) Schematic dia-
gram of the human 
 
TCRD
 
 gene complex. The six “classical” V
 
 
 
 gene seg-
ments (blue) are scattered between V
 
 
 
 gene segments (black). Because  
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various TCR genes must be determined by the accessibility
of gene segments to RAG enzymes. Evidence suggests that
promoter and enhancer activity that is controlled by tran-
scription factors regulate V(D)J recombination by modulat-
ing chromatin structures and rendering gene segments acces-
sible to RAG cleavage (5, 6).
For obvious reasons T cell development mainly is studied
in the mouse. Real-time quantitative PCR (RQ-PCR) and
DNA microarray techniques allow careful analysis of small
cell numbers. In this study we assessed the precise TCR
gene configuration and the gene expression profiles of thy-
mic subsets by RQ-PCR and Affymetrix DNA microarrays.
By combining these two techniques we aimed for the identi-
fication of factors that play a role in regulating human TCR
gene recombination.
 
RESULTS AND DISCUSSION
Definition of T cell populations
 
CD34
 
 
 
 lineage negative “stem cell-like” cells were obtained
from umbilical cord blood (UCB) and CD34
 
 
 
CD38
 
 
 
CD1a
 
 
 
, CD34
 
 
 
CD38
 
 
 
CD1a
 
 
 
, CD34
 
 
 
CD38
 
 
 
CD1a
 
 
 
, ISP
CD4
 
 
 
, DP CD3
 
 
 
, DP CD3
 
 
 
, SP CD4
 
 
 
, and SP CD8
 
 
 
subpopulations were obtained from thymi which repre-
sented consecutive stages of T cell development (Fig.
S1, available at http://www.jem.org/cgi/content/full/
jem.20042524/DC1). TCR
 
  
 
- and TCR
 
  
 
-expressing cells
were obtained from thymic samples and peripheral blood
mononuclear cells. Cells from five donors were pooled to
reduce intrasample variation and all subsets were isolated
twice from different donor pools.
 
Determination of TCR gene rearrangements by RQ-PCR and 
GeneScan analysis
 
TCR gene rearrangement analysis was performed in dupli-
cate and on the two independently purified subsets (average
is shown). The primers and TaqMan probes are listed in Ta-
ble S1 (available at http://www.jem.org/cgi/content/full/
jem.20042524/DC1) and do not amplify germline DNA.
 
TCRD
 
The D
 
 
 
2-D
 
 
 
3 rearrangement was detected first in the earliest
CD34
 
 
 
CD38
 
 
 
CD1a
 
 
 
 thymic subset, much earlier during de-
velopment than in our previous Southern blotting–based re-
port (4). D
 
 
 
2-D
 
 
 
3 rearrangements reached maximum levels
in the subsequent CD34
 
 
 
CD38
 
 
 
CD1a
 
 
 
 stage and declined to
low levels in the later subsets (Fig. 1 B). The initial D
 
 
 
2-D
 
 
 
3
wave was followed by D
 
 
 
2-J
 
 
 
1 rearrangements which were
detectable at low levels in CD34
 
 
 
CD38 CD1a  cells, in-
creased in CD34 CD38 CD1a  cells, and peaked in
CD34 CD38 CD1a  cells (Fig. 1 C). Complete V 1-J 1 or
V 2-J 1 rearrangements were detected first in CD34 
CD38 CD1a  cells, increased to peak levels in CD4  ISP
cells, and declined thereafter when the majority of thymocytes
differentiated further into the TCR   lineage (Fig. 1 D).
During TCR   T cell lineage development, the TCRD gene
is deleted from the TCRA/D gene complex (2, 7) which
results in the formation of a T cell receptor excision circle
(TREC) that may contain V -J 1 rearrangements. TRECs do
not replicate on cell division; consequently, they are diluted
out in proliferating, developing T cells (2). Ki67 staining dem-
onstrated high percentages of proliferating cells within the hu-
man ISP and DP CD3  thymic subsets (unpublished data).
This proliferation likely accounts for the observed decline in
V -J 1 rearrangements after the ISP stage. The V 1 gene seg-
ment seemed to be used preferentially in postnatal TCR   
thymocytes which is in sharp contrast to the well-described
preferential V 2 usage by peripheral TCR    T cells (Fig. 1
D; reference 8). We detected very low V -D 3 levels in the
thymic subsets; this represents a minor pathway to initiate
TCRD gene rearrangement in postnatal thymus (Fig. 1 E).
TCRG
The first TCRG rearrangements (V -J 1.1/2.1) were de-
tected in the CD34 CD38 CD1a  thymic subset, earlier
than we reported previously (4), and one stage after the in-
itiation of TCRD rearrangement. These rearrangements
peaked in CD34 CD38 CD1a  thymocytes and decreased
to a relatively constant level in subsequent subsets (Fig. 1 G).
V -J 1.3/2.3 rearrangements were observed first in CD34 
CD38 CD1a  cells after which they increased rapidly and
by far exceeded V -J 1.1/2.1 rearrangements from the ISP
stage onward (Fig. 1 H). Peripheral TCR    and TCR   
T cells revealed lower J 1.3/2.3 usage than their thymic
counterparts (Fig. 1 H). In thymocytes, J 1.2 was used at
very low frequency, but massive positive selection for the
J 1.2 segment occurred in peripheral TCR    T cells (Fig.
1 I; reference 8).
TCRB
D 1-J 1 rearrangements were detected first at low levels in
the CD34 CD38 CD1a  population and increased thereaf-
ter from CD34 CD38 CD1a  to CD4  ISP cells (Fig. 2
B). D 2-J 2 rearrangements were detected first at low levels
in CD34 CD38 CD1a  cells, one differentiation stage after
D 1-J 1 rearrangements (Fig. 2 B). The seemingly lower
levels of D -J  in DP CD3  probably are caused by varia-
tion within the lower range of detection of our assay and
likely do not represent a true decrease.
Because of the complexity of the TCRB locus, V -J 
rearrangements were determined by using nonquantitative
V 4, V 5, and V 6 also are recognized as V  gene segments, their V  gene 
code is given in parentheses (adapted from reference 9). (B) Analysis 
of D 2-D 3 rearrangement. (C) Analysis of D 2-J 1 rearrangement. 
(D) Analysis of V 1-J 1 and V 2-J 1 rearrangements. (E) Analysis of V -D 3 
rearrangement. (F) Schematic diagram of the human TCRG gene complex. 
Only the rearrangeable V  gene segments are depicted in blue (functional 
V ) or gray (nonfunctional V ). For the J  gene segments both nomencla-
tures are used (adapted from reference 9). (G) Analysis of V  to J 1.1 and 
J 2.1 rearrangements. (H) Analysis of V  to J 1.3 and J 2.3 rearrange-
ments. (I) Analysis of V  to J 1.2 rearrangements.TCR REARRANGEMENT AND GENE EXPRESSION IN T CELL DEVELOPMENT | Dik et al. 1718
Figure 2. RQ-PCR and GeneScan analysis of TCRB rearrangements 
in human T cell development and in mature T cells. (A) Schematic dia-
gram of the human TCRB gene complex. (B) Analysis of D  to J  rear-
rangements. (C) Schematic diagram of V -J  rearrangements as deter-JEM VOL. 201, June 6, 2005 1719
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GeneScan analysis (9). The CD34 CD38 CD1a  thy-
mocytes contained low levels of the first V -J  rearrange-
ments in which J 2 gene segments were used exclusively
(Fig. 2 D), much earlier than we described before (4). From
the ISP subset onward, V -J  rearrangements were in-frame
as shown by the triplet peaks (Fig. 2 E) and were retained
throughout all subsequent stages of development (Fig. 2,
E–H). Previous reports suggested that TCR -selection in
humans is initiated at the ISP/DP stages of T cell develop-
ment (4, 10, 11), but the three-nucleotide spacing of the
peaks in our GeneScan analysis suggest that selection for
in-frame TCRB already occurs at the transition from CD34 
CD38 CD1a  to ISP. From the DP CD3  fraction, V -J 1
rearrangements also were present, although they were less
abundant than V -J 2 rearrangements (Fig. 2 F; tube A).
For V -J  rearrangements, usage of J 2 gene segments was
preferred over J 1 (Fig. 2, D–H). TCR    thymocytes
contained no V -J 1 rearrangements but did contain V -J 2
rearrangements (Fig. 2 H).
TCRA
Because of large numbers of rearrangable V  ( 54) and J 
(61) gene segments (2), we could not design a multiplex
RQ-PCR for reliable quantification of all V -J  rearrange-
ments. Instead, we aimed for an alternative approach in
which we used different indirect measures to study TCRA
recombination.  TCRA recombination is initiated by the
transcription of T-early   (TEA) in order to open the 5  site
of the J  cluster, which is followed by TCRD deleting rear-
rangements, particularly the  REC- J  rearrangement.
These initiating events are followed by multiple, consecutive
V -J  rearrangements (7, 12).
To study initiation of TCRA rearrangement we deter-
mined the level of TEA-C  transcripts as well as the occur-
rence of  REC- J  rearrangements. TEA-C  transcripts
started to increase in CD34 CD38 CD1a  cells and
reached peak levels in ISP and DP cells after which they de-
clined again (Fig. 3 B).  REC- J  rearrangements were de-
tected first in ISP cells and reached peak levels in SP and
TCR    thymocytes (Fig. 3 C). These data show that
TCRA rearrangement already has started in the ISP cell pop-
ulation but that there are still cells within the CD3  DP
population that start rearrangement of the (most likely) sec-
ond  TCRA allele. Although TEA-C  transcripts and
 REC- J  rearrangements are good measures for initiation
of TCRA rearrangement, they cannot be used for quantifica-
tion of the actual TCRA rearrangements. TEA-C  is an
mRNA product that cannot be extrapolated simply to the
actual level of TCRA rearrangements. Quantification of
 REC- J  is complex because it is influenced strongly by
ongoing V -J  rearrangements and the consequently pro-
duced TRECs (containing  REC- J ), whereas the amount
of TRECs (and their dilution) is heavily dependent on the
fraction of proliferating cells within specific subsets. There-
fore, extra accumulation of TRECs may explain the rela-
tively high  REC- J  levels in nonproliferating SP cells as
compared with the preceding proliferating stages.
In an attempt to quantify TCRA recombination, we de-
termined loss of germline TCRA DNA based on the disap-
pearance of germline  J  as an indirect measure for TCRA
rearrangements. For this approach we used DNA from
CD34  lin  UCB cells as 100% germline reference. Germ-
line TCRA clearly declined from the CD34 CD38 CD1a 
stage onward with a major decline when ISP cells progress
toward DP cells (Fig. 3 D). The low levels of germline
TCRA in DP CD3  cells indicate that extensive TCRA re-
arrangement has occurred at this stage. The apparent incon-
sistency with the relatively low levels of  REC- J  in these
DP CD3  cells can be explained by the fact that TRECs
that contain  REC- J  are diluted-out rapidly in these
heavily proliferating cells and that other TCRD deleting re-
arrangements can occur as well, such as  REC-J 58 and
V - J  (7). Our approach is only suitable for quantification
of major decreases in germline TCRA, which occur at early
stages of T cell development (ISP/CD3- DP); however, it is
much more difficult to measure additional TCRA rearrange-
ments accurately at the later stages of T cell development be-
cause germline  J  (e.g., due to  REC-J 58 rearrange-
ments) remains detectable on TRECs and the difficulty of
detecting further decreases within the 5–10% germline
TCRA that is present in these stages.
We conclude that TCRA rearrangements are initiated
when thymocytes progress from CD34 CD38 CD1a  toward
the ISP stage—which is much earlier than reported previously
(10)—and apparently are ongoing until the CD3  DP stage.
Microarray analysis
A total of 3848 probe sets underwent a significant change
between any two successive stages of differentiation. Raw
microarray data can be found at http://www.ebi.ac.uk/
miamexpress, MIAME accession no. E-MEXP-337, and http:
//franklin.et.tudelft.nl, including a gene search browser. The
expression levels of these probe sets were used to calculate a
correlation coefficient between all possible pairs of microarrays
and revealed high correlation between biological repeats
(Fig. S2, available at http://www.jem.org/cgi/content/full/
jem.20042524/DC1). This allowed us to use the average ex-
pression values of the two arrays that were performed per sub-
set (obtained from five pooled thymi) for further analysis. Hi-
erarchical clustering of the 3848 probe sets was performed and
is described in Fig. S3 and Table S2 (available at http://
www.jem.org/cgi/content/full/jem.20042524/DC1).
mined by GeneScan analysis. The primers for the J 1 cluster were 
hexachloro-6-carboxy-fluorescein (HEX)-labeled, whereas primers for the 
J 2 cluster were 6-carboxy-fluorescein (FAM)-labeled and yielded a green 
or blue signal upon GeneScan analysis, respectively. Analysis of V -J  
rearrangements in CD34 CD38 CD1a  cells (d), ISP cells (e), DP CD3  cells 
(f), TCR    thymocytes (g) and TCR    thymocytes (h).TCR REARRANGEMENT AND GENE EXPRESSION IN T CELL DEVELOPMENT | Dik et al. 1720
Of special interest for TCR -selection and initiation of
TCRA rearrangement is that PTCRA (pT ) expression in-
creased in the CD34 CD38 CD1a  stage, peaked in the
CD34 CD38 CD1a  and ISP stages, after which it de-
clined (Table S2). Mouse microarray data (13) have shown a
similar expression pattern of pT , with a minor peak at
DN3 and a larger peak at the DP CD3  stage. Experiments
with pT  mutant mice indicate that TCR -selection in the
mouse occurs at DN3 (14), and that TCRA recombination is
initiated after TCR -selection has occurred (14). Here, we
show that initiation of TCRA recombination starts in
CD34 CD38 CD1a  cells. Therefore, the analogous pT 
expression between mice and men, our TCRB GeneScan,
and our TCRA recombination data indicate that human
TCR -selection occurs at the CD34 CD38 CD1a  stage
instead of the previously suggested ISP/DP stage (4, 10, 11).
To identify candidate transcription factors that are in-
volved in regulating TCR recombination, the list of 3848
probe sets was filtered based on Gene Ontology annotation
(transcriptional regulation and DNA binding) which yielded
a final list of 446 probe sets that encoded a total of 361 genes
(Fig. S4, available at http://www.jem.org/cgi/content/full/
jem.20042524/DC1). Expression of genes that are associated
with T cell commitment/differentiation and/or V(D)J re-
combination, such as NOTCH1, HES1, GATA3, BCL11B,
RAG1,  RAG2, and DNTT (TdT), increased strongly in
early T cell differentiation.
To determine which genes may have a role in regulating
TCR rearrangement, hierarchical cluster analysis was per-
formed (Fig. 4 A). The 446 probe sets were divided into 15
clusters; the prototypic expression patterns are depicted in Fig.
4 B. Based on the TCR rearrangement patterns (as described
above) and the prototypic gene expression patterns, we propose
that clusters 3, 5, 6, 7, 14, and 15 (Fig. 4 B, asterisk) contain
genes that may encode candidate factors for initiation/regula-
tion of TCR rearrangements because the genes that are present
in these clusters show higher expression at the moments at
which active TCR gene rearrangement occurs. Genes that are
Figure 3. RQ-PCR analysis of initiating events around TCRA rear-
rangement in human T cell development and mature T cells. (A) Sche-
matic diagram of the human TCRA gene complex. The TEA element (red) 
forms a sterile mRNA with C  sequences. The TCRD deleting elements 
 Rec and  J  are also indicated. (B) Analysis of TEA-C  mRNA expression. 
Due to shortage of material, TEA expression was only determined once. 
(C) Analysis of the TCRD deleting rearrangement  Rec- J . (D) Analysis of 
“remaining” TCRA germline DNA.JEM VOL. 201, June 6, 2005 1721
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present in clusters 3, 5, 6, 7, 14, and 15 are presented in Table I;
those of all 15 clusters are shown in Table S3 (available at http://
www.jem.org/cgi/content/full/jem.20042524/DC1).
We propose that clusters 3, 5, and 6 contain genes that
are common for the rearrangement of all four TCR genes.
Cluster 5 likely contains genes that are important for the reg-
ulation of TCRD,  TCRG, and TCRB rearrangements,
whereas cluster 3 likely contains genes that need to be ex-
pressed at a higher level when TCRA rearranges. These
clusters contain DNTT (cluster 6), RAG 1/RAG 2 (cluster
3), and genes that encode factors, such as NOTCH1 (cluster
6), RORC (cluster 3), SMARCA4 (BRG1) (clusters 6 and
3), H2AFX (cluster 3), that previously were linked to regu-
lation of TCRG, TCRB, or TCRA rearrangements (15–18).
Genes in cluster 7, 14, and 15, such as SPIB, ICSBP1,
TCF4, CREB1, ETS1, and LEF-1, may encode factors that
are involved in regulating TCRA rearrangements as well as
allelic exclusion of the TCRB locus. These are discussed in
the supplemental Results and Discussion (available at http://
www.jem.org/cgi/content/full/jem.20042524/DC1).
Novel insights into human T cell development
We confirm that TCR loci rearrange in a highly ordered
way (TCRD-TCRG-TCRB-TCRA) and defined sequential
rearrangement steps of TCRD, TCRG, TCRB, and initia-
tion of TCRA recombination to specific human thymic sub-
sets. Importantly, our data show that recombination of the
TCR genes occurs earlier during human T cell development
than previously reported (4, 10). Given that TCRD rear-
rangement starts at DN1 in mice, followed by TCRG in
DN2 and TCRB in DN2, but especially DN3 (1, 19), the
human CD34 CD38 CD1a , CD34 CD38 CD1a , and
CD34 CD38 CD1a  subsets resemble murine early DN1
(CD44 CD25 CD117 ), late DN1/DN2 (CD117  DN1;
CD44 CD25 ), and DN3 (CD44 CD25 ) stages, respec-
tively. However, the relative frequency of DN1 cells in mice
is higher than that of the corresponding human subset
(CD34 CD38 CD1a ). We also demonstrate that TCR -
selection and initiation of TCRA rearrangement already oc-
cur at the CD34 CD38 CD1a  stage of human T cell de-
velopment, instead of the ISP/DP stage (4, 10, 11), similar
to the mouse (i.e., TCR -selection occurs at DN3 in the
mouse; reference 14).
Based on the TCR rearrangement data and the expres-
sion profile of key recombination and differentiation genes
(e.g., RAG1, RAG2, and PTCRA), we show that human
and mouse T cell development are much more similar than
assumed previously. In addition, candidate factors for regula-
tion of TCR recombination are identified.
We propose an updated human T cell differentiation
model as shown in Fig. S5 (available at http://www.jem.org/
cgi/content/full/jem.20042524/DC1). These novel data help
ters that contain genes that are potentially important in regulating TCR 
rearrangements. N, indicates the number of probe sets in a cluster.
Figure 4. Analysis of probe sets related to transcriptional regula-
tion. (A) Hierarchical clustering of 446 probe sets differentially ex-
pressed over the various stages and related to transcriptional regulation 
and DNA binding. (B) z-score trend representation for each cluster de-
duced from the 446 probe sets. Cluster codes (1–15) are shown in the 
top right corner, z-score on the y axis, subsets on the x axis. The gray 
area represents 1 SD. The asterisk in the top right corner indicates clus-TCR REARRANGEMENT AND GENE EXPRESSION IN T CELL DEVELOPMENT | Dik et al. 1722
to bridge gaps in our understanding of human T cell develop-
ment, and also should provide insight into the development
of T cell acute lymphoblastic leukemias and T-SCID.
MATERIALS AND METHODS
Purification of thymocyte subsets, CD34  lineage  cells, and ma-
ture peripheral T cells. For the isolation of CD34  lin  UCB cells and
thymocyte subsets, total mononuclear cells or thymocytes from five donors
were pooled to reduce intrasample variation. CD34  subsets were prepuri-
fied by magnetic-activated cell-sorted beads and further purified by cell
sorting to  96% purity.
RQ-PCR analyses of TCR gene rearrangements. This essentially was
performed as described previously (20). For the various TCR recombina-
tions, cell lines/diagnostic samples were selected as clonal control DNA.
GeneScan analysis for complete and in-frame V -J  gene rear-
rangements. This was done by two multiplex PCR reactions as described
by the BIOMED-2 Concerted Action (9).
TEA expression by RQ-PCR analyses. Expression of TEA was de-
fined by calculating the ratio of TEA to the average value of the control
genes ABL and GUSB.
Microarray analysis. Affymetrix microarray analysis essentially was done
as described previously (21) and according to Minimum Information About
a Microarray Experiment guidelines (www.mged.org/Workgroups/MIAME/
miame.html).
Statistical analysis. Probe intensity background was removed using ro-
bust multichip analysis (22). The intensity levels were quantile normalized
Table I. Transcription and DNA-binding–related genes with expression profiles that correlate with TCR gene rearrangements in 
human T cell development
Common TCR
Common TCR
D, G, B   A
Common TCR
A   B, G, D TCRA/allelic exclusion TCRB
Category Cluster 6 Cluster 5 Cluster 3 Cluster 7 Cluster 14 Cluster 15
Transcription factor/
coregulator of
transcription BAZ1B BAZ2B AEBP1 ACYP2 BRD8 ABCA7
ETS2  FOS CBFA2T3 BCL11A CNOT3 ARNTL
HMGB3 HES1 E2F1 CD86 CREB1 BCL6
KLF4 IRF1 FOXM1 CUTL2 FALZ CENTB1
MYB STAT4 GFI1 ICSBP1 (IRF8) IFI16 ELF1
NOTCH1 TCEAL1 MYBL1 IRF7 ILF3 ETS1
TCFL1 MYBL2 MNDA LEF1 GATA3
NFATC3 MYCL1 LEREPO4 GMEB2
NOTCH3 SPIB M96 HTATIP
ORC6L TCF4 NFYA LEF1
RORC NR2C1 LRRFIP1
SAP30 PWP1 MXD4
TFDP2 SOLH TCF7
TMPO TAF5 ZNF297B
TRIP13 TBDN100
TTF1 TCF12 (HEB)
WHSC1 TCF8
ZNF423 TFAM
         ZNFN1A1 (IKAROS)  
Recombination DNTT (TdT) RAG1
RAG2
Chromatin
remodeling H2AFY   CHAF1A   HDAC4 HDAC7A
SMARCA4 EZH2 YY1 SATB1
H2AFX
HMGB2
HMGN2
     SMARCA4     
DNA repair MCM2 BRCA1 BTG2 BTG2
MCM6 MCM7
   PTTG1     JEM VOL. 201, June 6, 2005 1723
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(23). Array groups (two biologically independent arrays per group) that cor-
responded to the development stages were compared based on the perfect
match probe intensity levels only (22), by performing a per-probe set two-
way analysis of variance (with factors “probe” and “stage”). The p-values
were adjusted for multiple testing using  idák step-down adjustment (24)
and all differences with adjusted p-values  0.05 were considered to be sig-
nificant. For Fig. S2, expression values were log2-transformed and the per-
probe set geometric mean was subtracted. Further analysis was performed
using Genlab software, running under Matlab (http://www.genlab.
tudelft.nl). After per-probe set normalization to zero mean and unit stan-
dard deviation (z-score), a hierarchical clustering (complete linkage) was
calculated based on Pearson correlation. The number of clusters k was de-
termined by looking for a local minimum of the Davies-Bouldin index cal-
culated for k   1,  . . . , 30 (25).
Online supplemental material. All methods are described in more detail
as supplemental Materials and methods online. Additional Results and Dis-
cussion, as well as Figs. S1–S5 and Tables S1–S3, are provided online, as
well. Online supplemental material is available at http://www.jem.org/cgi/
content/full/jem.20042524/DC1.
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